Metsera, Inc., a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced positive topline results from the Phase 1 ...

Recently debuted Metsera is unfolding some phase 1 data for its GLP-1 receptor agonist, revealing a 7.5% reduction in body ...

Chad Jessup, who previously worked on Destiny 2 expansions and the Xbox 360 version of Shadowrun, posted about emptying his ...

There are reasons to believe Half-Life 3 might be in the works, but before it gets here, more people need to play Valve’s ...

What's the coolest thing you've ever found while cleaning out your garage or a relative's storage unit? For former game ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...